Clinical trial
Biomarkers of Response to Taxotere in Hormone-Refractory Prostate Cancer
NCT01160705 is registered in ClinicalTrials.gov with Cancer Trials Ireland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biomarkers of Response to Taxotere in Hormone-Refractory Prostate Cancer
- Lead sponsor
- Cancer Trials Ireland
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2009
- Completion date
- Not reported
- Enrollment
- 73 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic cancer, prostate cancer